Article
Effect of cholecalciferol on serum hepcidin and parameters of anaemia and CKD-MBD among haemodialysis patients: a randomized clinical trial.
Scientific reports - 23 Sept 2020
Obi Yoshitsugu, Yamaguchi Satoshi, Hamano Takayuki, Sakaguchi Yusuke, Shimomura Akihiro, Namba-Hamano Tomoko, Mikami Satoshi, Nishi Osamu, Tanaka Motoko, Kamoto Akihito, Obi Yasue, Tomosugi Naohisa, Tsubakihara Yoshiharu, Isaka Yoshitaka
Abstract excerpt
In this multicentre double-blind randomized clinical trial, we investigated the effects of oral cholecalciferol supplementation on serum hepcidin and parameters related to anaemia and CKD-MBD among haemodialysis patients. Participants were assigned in a 2:2:1:1 ratio to either (1) thrice-weekly 3,000-IU cholecalciferol, (2) once-monthly cholecalciferol (equivalent to 9,000 IU/week), (3) thrice-weekly placebo, or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
